Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Recruiting Observational Study
Non-small Cell Lung Cancer (NSCLC)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
55 (estimated)
Sponsor
Bristol-Myers Squibb · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patients * Aged ≥18 years at the time of enrollment in the study * Resident of the US, Germany, or Japan * Able to read, speak, and understand English, German or Japanese * Diagnosed with resectable phase II to IIIB non-small cell lung cancer (NSCLC) Physicians * Resident of …
Contacts

BMS Study Connect Contact Center www.BMSStudyConnect.com

855-907-3286

Clinical.Trials@bms.com

CONTACT

First line of the email MUST contain NCT # and Site #.

CONTACT